Skip to main content

Table 2 Comparison of changes in disease characteristics before and after treatment between the two groups according to UPDRS scores

From: Effects of rasagiline combined with levodopa and benserazide hydrochloride on motor function and homocysteine and IGF-1 levels in elderly patients with Parkinson’s disease

 

Observation group

Control group

Before Treatment (score)

After Treatment (score)

Before Treatment (score)

After Treatment (score)

Spiritual, behavioral and emotional

6.13 ± 1.12

3.28 ± 0.66

5.84 ± 0.32

4.28 ± 0.88

Daily Activities

16.72 ± 1.06

10.32 ± 0.54

17.21 ± 0.68

14.32 ± 0.96

Motion function

12.46 ± 0.8

7.86 ± 0.82

11.08 ± 1.01

9.77 ± 0.46

Post-treatment complications

3.38 ± 0.56

1.19 ± 0.34

4.01 ± 0.97

2.27 ± 0.65

Rating

38.69 ± 3.54

22.56 ± 2.36

38.14 ± 2.98

30.64 ± 2.95